Armin Scherhag

6.1k citations
60 papers · 4.4k indexed · 2 hit papers · h-index 23
Topics
Erythropoietin and Anemia Treatment (17 papers)Heart Failure Treatment and Management (17 papers)Cardiovascular Function and Risk Factors (9 papers)

In The Last Decade

Armin Scherhag

60 papers receiving 4.2k citations

Hit Papers

Normalization of Hemoglobin Level in Patients with Chroni...2003202620102018200620034008001.2k

Peers

Armin Scherhag
Comparison fields: 5 of 116
  • Cardiology and Cardiovascular Medicine 2.2k
  • Hematology 1.6k
  • Nephrology 1.0k
  • Genetics 525
  • Endocrinology, Diabetes and Metabolism 395
Replace Adel R. Rizkala with:
Adel R. Rizkala United States
Bruce Spinowitz United States
Tetsuya Babazono Japan
Michael M. Givertz United States
Christiane Drechsler Germany
José L. Cangiano Puerto Rico
Erik Lerkevang Grove Denmark
Steven Joseph Haas Australia
Darlington O. Okonko United Kingdom
Vera Krane Germany
Armin Scherhag relative to Adel R. Rizkala United States Adel R. Rizkala's profile →
Citations per field
00.5×2.9×
Adel R. Rizkala · 1×
Citations per year

Countries citing papers authored by Armin Scherhag

Since Specialization
Citations

This map shows the geographic impact of Armin Scherhag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Scherhag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Scherhag more than expected).

Fields of papers citing papers by Armin Scherhag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armin Scherhag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Scherhag. The network helps show where Armin Scherhag may publish in the future.

Co-authorship network of co-authors of Armin Scherhag

This figure shows the co-authorship network connecting the top 25 collaborators of Armin Scherhag. A scholar is included among the top collaborators of Armin Scherhag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armin Scherhag. Armin Scherhag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 37
3 60
4
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemiabreakdown →
1470
5 27
6 3
7 67
8 6
9 32
10 55
11 2
12 3
13 3
14 3
15 108
16 2
17 11
18 7
19 5
20
[Analgosedation (managed anesthesia care--MAC) with propofol and piritramide for controlled cyclophotocoagulation of the eye].
2

About Armin Scherhag

Armin Scherhag is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Nephrology, having authored 60 papers that have together received 4.4k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (17 papers), Heart Failure Treatment and Management (17 papers) and Cardiovascular Function and Risk Factors (9 papers). The work is most often cited by research in Nephrology (1.0k citations), Hematology (1.6k citations) and Cardiology and Cardiovascular Medicine (2.2k citations). Armin Scherhag has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Hans-Ulrich Burger, Francesco Locatelli, Kai‐Uwe Eckardt, Dimitrios Tsakiris, Naomi Clyne, Tilman B. Drüeke, Iain C. Macdougall, Willem J. Remme, Michel Komajda and Marco Metra. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026